Healthy
Showing NaN - NaN of 135
Healthy Trial in New Haven (BIIB118)
Completed
- Healthy
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Feb 15, 2021
Healthy Trial in New Haven (330 mg pregabalin controlled release, 300 mg pregabalin immediate release)
Completed
- Healthy
- 330 mg pregabalin controlled release
- 300 mg pregabalin immediate release
-
New Haven, ConnecticutPfizer Investigational Site
Jan 26, 2021
Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg,
Completed
- Healthy
- Pregabalin controlled release, 330 mg, 600- 750 calorie
- +2 more
-
New Haven, ConnecticutPfizer Investigational Site
Jan 21, 2021
Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg,
Completed
- Healthy
- Pregabalin controlled release, 330 mg, 400 to 500 calorie
- +3 more
-
New Haven, ConnecticutPfizer Investigational Site
Jan 21, 2021
Healthy Trial in New Haven (Pregabalin ER)
Completed
- Healthy
- Pregabalin ER
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Jan 15, 2021
Healthy Trial in New Haven (PF-07304814, Placebo)
Completed
- Healthy
- PF-07304814
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 4, 2021
Healthy Trial in New Haven (LY3372689, [18F]LSN3316612)
Completed
- Healthy
- LY3372689
- [18F]LSN3316612
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Nov 3, 2020
Healthy Trial in New Haven (tofacitinib modified release (MR))
Completed
- Healthy
- tofacitinib modified release (MR)
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Oct 27, 2020
Healthy Trial in New Haven (PF-06650833 alone, PF-06651600 alone, PF-06650833 together with PF-06651600)
Completed
- Healthy
- PF-06650833 alone
- +2 more
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
May 18, 2020
Healthy Trial in New Haven (PF-05221304 Formulation A, PF-05221304 Formulation B)
Completed
- Healthy
- PF-05221304 Formulation A
- PF-05221304 Formulation B
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
May 18, 2020
Healthy Trial in New Haven (LY3372689, [18F]LSN3316612)
Completed
- Healthy
- LY3372689
- [18F]LSN3316612
-
New Haven, ConnecticutInvicro, Institute for Neurodegenerative Disorders
Apr 21, 2020
Healthy Trial in New Haven (flavor and sweetener, flavor and nicotine, flavor, nicotine and sweetener)
Completed
- Healthy
- flavor and sweetener
- +3 more
-
New Haven, ConnecticutThe John B Pierce Laboratory
Mar 4, 2020
Nicotine Dependence, Healthy Trial in New Haven (Amphetamine)
Completed
- Nicotine Dependence
- Healthy
-
New Haven, ConnecticutYale University
Mar 4, 2020
Healthy Trial in New Haven (Tofacitinib tablet, Tofacitinib Oral Solution)
Completed
- Healthy
- Tofacitinib tablet
- Tofacitinib Oral Solution
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 8, 2020
Healthy Trial in New Haven (PF-04958242, Itraconazole)
Completed
- Healthy
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Dec 20, 2019
Healthy Trial in New Haven (PF-04958242, Placebo)
Completed
- Healthy
- PF-04958242
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Dec 23, 2019
Healthy Trial in New Haven (Glucose100, Glucose50, Glucose42)
Terminated
- Healthy
- Glucose100
- +3 more
-
New Haven, ConnecticutYale Center for Clinical Investigation Church Street Research Un
Nov 25, 2019
Healthy Trial in New Haven (PF-04958242 capsule, PF-04958242 oral solution)
Completed
- Healthy
- PF-04958242 capsule
- PF-04958242 oral solution
-
New Haven, ConnecticutPfizer Investigational Site
Nov 19, 2019
Healthy Trial in New Haven (PF-06946860, Placebo)
Completed
- Healthy
- PF-06946860
- Placebo
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Nov 6, 2019
Healthy Trial in New Haven (PF-04965842, Probenecid)
Completed
- Healthy
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Oct 17, 2019
Healthy Trial in New Haven (Within-Subject Active vs Placebo Topical Applications, Within-Subject Active vs. Placebo Topical
Completed
- Healthy
- Within-Subject Active vs Placebo Topical Applications
- Within-Subject Active vs. Placebo Topical Applications
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 21, 2019
Healthy Trial in New Haven (Positron Emission tomography, PET Scan with PF-03654746)
Completed
- Healthy
- Positron Emission tomography
- PET Scan with PF-03654746
-
New Haven, Connecticut
- +2 more
Feb 28, 2019
Healthy Trial in New Haven (PF-06463922, rifampin)
Completed
- Healthy
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Aug 22, 2018
Healthy Trial in New Haven (PF-04447943, Placebo, Moxifloxacin)
Completed
- Healthy
- PF-04447943
- +2 more
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Jun 18, 2018